Nothing Special   »   [go: up one dir, main page]

PT1053329E - Proteína psaa lipidada recombinante, métodos de preparação e utilização - Google Patents

Proteína psaa lipidada recombinante, métodos de preparação e utilização Download PDF

Info

Publication number
PT1053329E
PT1053329E PT99903011T PT99903011T PT1053329E PT 1053329 E PT1053329 E PT 1053329E PT 99903011 T PT99903011 T PT 99903011T PT 99903011 T PT99903011 T PT 99903011T PT 1053329 E PT1053329 E PT 1053329E
Authority
PT
Portugal
Prior art keywords
proteins
lipidated psaa
methods
preparation
lipidated
Prior art date
Application number
PT99903011T
Other languages
English (en)
Inventor
Edwin W Ades
George M Carlone
Barun K De
Jacquelyn S Sampson
Robert C Huebner
Original Assignee
Ct Disease Contr & Prevention
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct Disease Contr & Prevention filed Critical Ct Disease Contr & Prevention
Publication of PT1053329E publication Critical patent/PT1053329E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT99903011T 1998-02-03 1999-01-14 Proteína psaa lipidada recombinante, métodos de preparação e utilização PT1053329E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1778298A 1998-02-03 1998-02-03

Publications (1)

Publication Number Publication Date
PT1053329E true PT1053329E (pt) 2010-01-04

Family

ID=21784518

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99903011T PT1053329E (pt) 1998-02-03 1999-01-14 Proteína psaa lipidada recombinante, métodos de preparação e utilização

Country Status (13)

Country Link
US (2) US7635486B1 (pt)
EP (1) EP1053329B1 (pt)
JP (1) JP4290875B2 (pt)
AT (1) ATE445015T1 (pt)
AU (1) AU2313199A (pt)
BR (1) BR9909097A (pt)
CA (1) CA2319404C (pt)
DE (1) DE69941505D1 (pt)
DK (1) DK1053329T3 (pt)
ES (1) ES2334185T3 (pt)
NZ (1) NZ525674A (pt)
PT (1) PT1053329E (pt)
WO (1) WO1999040200A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6903184B1 (en) 1998-03-02 2005-06-07 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Multiple antigenic peptides immunogenic against Streptococcus pneumonia
US20040092711A1 (en) * 2000-02-28 2004-05-13 Arico Maria Beatrice Hybrid expression of neisserial proteins
CA2416224C (en) * 2000-07-10 2015-08-25 Edwin W. Ades Multiple antigenic peptides immunogenic against streptococcus pneumoniae
MX339524B (es) 2001-10-11 2016-05-30 Wyeth Corp Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
CA2522751A1 (en) * 2003-04-16 2004-11-04 Wyeth Holdings Corporation Novel immunogenic compositions for the prevention and treatment of meningococcal disease
AR064642A1 (es) 2006-12-22 2009-04-15 Wyeth Corp Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi
RU2580620C2 (ru) 2010-08-23 2016-04-10 ВАЙЕТ ЭлЭлСи СТАБИЛЬНЫЕ КОМПОЗИЦИИ АНТИГЕНОВ Neisseria meningitidis rLP2086
NZ607224A (en) 2010-09-10 2014-11-28 Wyeth Llc Non-lipidated variants of neisseria meningitidis orf2086 antigens
SA115360586B1 (ar) 2012-03-09 2017-04-12 فايزر انك تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
SG10201911003QA (en) 2012-03-09 2020-01-30 Pfizer Neisseria meningitidis compositions and methods thereof
EP2964665B1 (en) 2013-03-08 2018-08-01 Pfizer Inc Immunogenic fusion polypeptides
KR102199096B1 (ko) 2013-09-08 2021-01-06 화이자 인코포레이티드 나이세리아 메닌지티디스 조성물 및 그의 방법
CN103773779B (zh) * 2013-12-31 2017-02-15 李越希 化学合成肺炎链球菌表面粘附素a的基因片段及表达、应用
RU2723045C2 (ru) 2015-02-19 2020-06-08 Пфайзер Инк. Композиции neisseria meningitidis и способы их получения
CN108884134A (zh) * 2015-12-10 2018-11-23 加拿大全国研究委员会 脂化肺炎链球菌抗原组合物、制备方法和用途
IL303108B2 (en) 2017-01-31 2024-07-01 Pfizer NEISSERIA MENINGITIDIS preparations and methods therefor

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993010238A1 (en) * 1991-11-14 1993-05-27 The Government Of The United States Of America As Represented By The Department Of Health And Human Services Pneumococcal fimbrial protein a vaccines
DE69636544T2 (de) * 1995-06-07 2007-06-06 Sanofi Pasteur, Inc. Expression von lipoproteinen
US6924112B1 (en) * 1997-12-04 2005-08-02 Biomethodes S.A.R.L. Cloning method by multiple-digestion, vectors for implementing same and applications
NO983911D0 (no) * 1998-08-26 1998-08-26 Norsk Hydro As Alginatkapsler til bruk ved behandling av hjernesvulst

Also Published As

Publication number Publication date
NZ525674A (en) 2005-01-28
ATE445015T1 (de) 2009-10-15
WO1999040200A1 (en) 1999-08-12
EP1053329A1 (en) 2000-11-22
CA2319404C (en) 2014-01-07
AU2313199A (en) 1999-08-23
DK1053329T3 (da) 2010-01-25
BR9909097A (pt) 2000-12-05
EP1053329B1 (en) 2009-10-07
US20100260802A1 (en) 2010-10-14
DE69941505D1 (de) 2009-11-19
CA2319404A1 (en) 1999-08-12
JP4290875B2 (ja) 2009-07-08
US7635486B1 (en) 2009-12-22
US7960535B2 (en) 2011-06-14
ES2334185T3 (es) 2010-03-05
JP2002505083A (ja) 2002-02-19

Similar Documents

Publication Publication Date Title
PT1053329E (pt) Proteína psaa lipidada recombinante, métodos de preparação e utilização
PL338478A1 (en) Immunological response in respect to hpv antigens induced by compositions comprising a hpv antigen and a shock protein or expression vector capable to express such protein
EP2275554A3 (en) Neisserial antigenic peptides
PL336295A1 (en) Modified tnfalpha molecule, dna encoding such molecule and vaccine comprising such tnfalpha molecule and such dna
FR2686896B1 (fr) Mutant attenue de listeria monocytogenes; souche recombinante de listeria monocytogenes, utilisation comme vecteurs heterologues d'antigenes vaccinal et utilisation comme vaccin ou composition diagnostique.
NZ333999A (en) GnRH-leukotoxin chimeric proteins for use in vaccines
CA2168459A1 (en) Fusion proteins containing the c-terminal of tetanus toxin linked to a heterologous protein
PT100781A (pt) Sequencias de dna codificadoras de proteinas de superficie externa, proteinas contendo as referidas sequencias, obtidas a partir de borrelia burgdorferi, e vacinas contendo as referidas proteinas
IL70776A (en) Recombinant dna molecule encoding at least one polypeptide displaying the immunogenicity of at least one merozoite antigen or asexual blood stage antigen of p.falciparum,vectors comprising the dna molecule,host cells transformed thereby,immunogenic polypeptides produced by host cells and compositions containing the polypeptides
WO2003065973A8 (en) Multivalent streptococcal vaccine compositions and methods for use
WO2003088995A3 (en) Mucin fusion polypeptide vaccines, compositions and methods of use thereof
AU4119996A (en) Carrier protein having an adjuvant effect, immunogenic complex containing same, preparation method therefor, nucleotide sequence and vaccine
NZ507983A (en) A polypeptide comprising the amino acid of an n- terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
WO2004007525A3 (en) Immunogenic composition comprising a fusion protein and a saponin adjuvant
MXPA03010527A (es) Composicion de vacuna.
CA2072095A1 (en) Outer membrane protein p1 and peptides of haemophilus influenzae type b
CA2006587A1 (en) Membrane proteins and peptides of haemophilus influenzae type b
AU2001239262A1 (en) Haemophilus influenza outer membrane protein and use thereof in vaccination
CA2182315A1 (en) Expression of heterologous proteins in attenuated bacteria using the htra-promoters
AU2001281943A1 (en) The t-cell protein (tzon7), peptides and antibodies derived therefrom and uses thereof
WO2001077329A8 (en) Human twik molecules and uses thereof
WO2004011496A3 (en) Novel t-cell proteins, peptides and antibodies derived therefrom and uses thereof
EP1535928A3 (en) Omp85 proteins of Neisseria gonorrhoeae and Neisseria meningitidis, compositions containing same and methods of use thereof
WO2002010379B1 (en) Modified cea and uses thereof
WO2001053344A3 (en) Chondromodulin-i related peptide